	Custo de Mercadoria Vendida		Data
ALKERMES	USD 46.21M	5.38M	2025-12
Alnylam Pharmaceuticals	USD 267.72M	67.57M	2025-12
Amarin	USD 16.89M	18.51M	2025-03
ANI Pharmaceuticals	USD 122.88M	6.86M	2025-12
Anika Therapeutics	USD 11.49M	35.48M	2025-03
Eisai	JPY 51.08B	5.56B	2025-12
Emergent BioSolutions	USD 381.2M	226.1M	2023-06
Esperion Therapeutics	USD 51.63M	22.2M	2024-09
GlaxoSmithKline	GBP 2.61B	377M	2025-12
Heron Therapeutics	USD 9.46M	1.61M	2024-09
Insmed	USD 46.16M	15.25M	2025-12
Ligand Pharmaceuticals	USD 11.9M	733K	2025-09
Merck	USD 3.32B	531M	2025-12
Nektar Therapeutics	USD 4.43M	5.3M	2024-09
Neurocrine Biosciences	USD 17.6M	246.4M	2025-12
Omeros	USD 33.16M	18.52M	2024-06
Pacira	USD 54.62M	6.02M	2025-12
Regeneron Pharmaceuticals	USD 584.6M	63M	2025-12
Roche Holding	CHF 8.48B	4.61B	2025-12
Sangamo BioSciences	2.42M	1.11M	2024-06
Surmodics	USD 33.03M	24.58M	2024-09
Ultragenyx Pharmaceutical	USD 29M	1.01M	2025-12
Veracyte	USD 39.28M	1.93M	2025-12
Vertex Pharmaceuticals	USD 466M	51.2M	2025-12

Heron Therapeutics Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.